EquityZen Growth Technology Fund LLC - Series 115
Raised
$577K
Investors
27
Min Invest
$0
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 115 is a Delaware-organized pooled investment fund filed by EquityZen on 2017-06-08, raising $577K from 27 investors under Rule 506(b) and Section 3(c)(1). This is part of EquityZen's multi-series pre-IPO secondary platform, which has filed over 1,800 related entities enabling accredited investor access to private company shares.
This pre-IPO fund follows the standard EquityZen platform structure: a single-company SPV using 506(b) private placement and 3(c)(1) fund exemptions, targeting accredited investors seeking exposure to late-stage private technology companies. The $21K average check size (27 investors, $577K total) is characteristic of retail-accessible pre-IPO vehicles compared to traditional institutional venture funds.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Inc.
Executive Officer, Director · New York, NY
Shriram Bhashyam
Executive Officer, Director · New York, NY
Assure Fund Management II LLC
Director · Salt Lake City, UT
Mateo Johnson
Executive Officer · Salt Lake City, UT
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
